UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032890
Receipt number R000037491
Scientific Title Establishing and developing support system for affection and emotions of severe stutterers
Date of disclosure of the study information 2018/06/06
Last modified on 2021/12/14 14:46:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishing and developing support system for affection and emotions of severe stutterers

Acronym

Establishing and developing support system for affection and emotions of severe stutterers

Scientific Title

Establishing and developing support system for affection and emotions of severe stutterers

Scientific Title:Acronym

Establishing and developing support system for affection and emotions of severe stutterers

Region

Japan


Condition

Condition

Stuttering

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To scientifically examine the efficacy of RASS for stuttering in order to provide an optimal support method for individuals with severe stuttering

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stuttering symptoms
Fear, Anxiety, and Behavior Scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

RASS efficacy on individuals who stutter

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Individuals with severe stuttering who provide written informed consent

Key exclusion criteria

Individuals who stutter that felt that doctors should perform treatment primarily in psychiatry departments

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Masashi
Middle name
Last name Shiomi

Organization

Kawasaki Medical School Hospital

Division name

Rehabilitation Center

Zip code

701-0192

Address

577,Matsushima,Kurashiki,Okayama

TEL

0864621111

Email

shiomi@mw.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Masashi
Middle name
Last name Shiomi

Organization

Kawasaki Medical School Hospital

Division name

Rehabilitation Center

Zip code

701-0192

Address

577,Matsushima,Kurashiki,Okayama

TEL

0864621111

Homepage URL


Email

shiomi@mw.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki University of Medical Walfare

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki University of Medical Walfare

Address

288,Matsushima,Kurashiki,Okayama

Tel

086-462-1111

Email

shiomi@mw.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 08 Month 22 Day

Date of IRB

2018 Year 07 Month 27 Day

Anticipated trial start date

2018 Year 07 Month 27 Day

Last follow-up date

2023 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 06 Day

Last modified on

2021 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037491


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name